Concepedia
Statistics
Publications
90
Citations
5.4K
H-Index
41
Active since
1993
Affiliations
Inserm(Current)
Hôpital de la Timone
Aix-Marseille Université
Assistance Publique – Hôpitaux de Paris
Bicêtre Hospital
Hérvè Chambost is an author at Inserm specializing in medicine, hematology, and hemostasis.
Publications per year
1993–2024
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor
Hideyuki Ikeda, Bernard Lethé, Frédéric Lehmann et al. · Immunity · 1997 · 772 citations · Full text
Life Sciences, Immunology, Oncology +16
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 323 citations
Medicine, Hematology, Pediatrics +17
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
Jenny Goudemand, Chantal Rothschild, Virginie Demiguel et al. · Blood · 2005 · 293 citations · Full text
Medicine, Hematology, Pharmacotherapy +14
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Johnny Mahlangu, Radosław Kaczmarek, Annette von Drygalski et al. · New England Journal of Medicine · 2023 · 191 citations · Full text
<i>PRAME</i>, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells
Van Baren, Hérvè Chambost, Ferrant et al. · British Journal of Haematology · 1998 · 186 citations · Full text
Medicine, Hematology, Oncology +16
1–5 of 90